- Partnership would focus on developing medical technology
- Qualcomm expanded a partnership with Novartis this month
GlaxoSmithKline Plc and Qualcomm Inc. are in discussions to form a joint venture as Glaxo looks for ways to develop medical technology, according to people with knowledge of the matter.
The talks are preliminary and nothing has been decided, said the people, who asked not to be named because the deliberations are private.
Glaxo follows other drugmakers teaming up with technology companies such as Google Inc. and International Business Machines Corp. to crunch health data and track patients taking their medicines. Glaxo has been using joint ventures to build scale to its businesses as it searches for growth. Its ViiV Healthcare business focuses on HIV treatments in partnership with Pfizer Inc. and Shionogi & Co., and it collaborates with Novartis AG on consumer healthcare.
Qualcomm earlier this month announced it was expanding a partnership with Novartis to improve data aggregation on clinical trials and to develop Internet-of-things connectivity for inhalers.
Representatives for Glaxo and Qualcomm declined to comment.